Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Avalon Globocare Corp (NASDAQ: ALBT) logo — Pioneering impactful biotechnology and advanced healthcare s...

Avalon Globocare Corp (NASDAQ: ALBT)

Pioneering impactful biotechnology and advanced healthcare services through innovative platforms like Avalon Cell and Avalon Rehab

Founded 2014 4 employees Post-IPO Equity Total: $25.15M Biopharma, Biotechnology +1

General Information

Company Name Avalon Globocare Corp (NASDAQ: ALBT)
Founded Year 2014
Founders / Decision Makers
Team member
Employees 4
Industries Biopharma, Biotechnology, Health Care
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Avalon Globocare Corp (NASDAQ: ALBT). To contact Avalon Globocare Corp (NASDAQ: ALBT), visit avalon-globocare.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Avalon Globocare Corp (NASDAQ: ALBT) compare?

A PDF of Avalon Globocare Corp (NASDAQ: ALBT) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Avalon Globocare Corp (NASDAQ: ALBT) soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Avalon Globocare Corp (NASDAQ: ALBT)

Avalon Globocare Corp (NASDAQ: ALBT) is a pioneering biotechnology and advanced healthcare services company, aiming to make a significant impact on the field through innovative platforms like Avalon Cell and Avalon Rehab. Founded in 2014, the company operates in the Biopharma, Biotechnology, and Health Care industries, focusing on advancing impactful biotechnology and clinical applications, as well as offering healthcare facility management.

The company received a significant $20.00M post-IPO equity investment on 03 September 2019, signifying investor confidence in its potential. While details about the specific investors are not provided, this injection of capital indicates external support and interest in the company's endeavors.

Business keywords: healthcare services, clinical-stage biotech, healthcare facility management, Avalon Cell, Avalon Rehab, transformative biotechnology, clinical applications

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $20.00M -
03 Sep 2019
Post IPO Equity $5.15M -
19 Dec 2017

Avalon Globocare Corp (NASDAQ: ALBT) Alternatives & Competitors

View All Alternatives
Avalon Globocare Corp (NASDAQ: ALBT) vs
Smart Immune
Smart Immune France

Pioneering thymus-empowered T-cell platform to fight cancer and infection

Grant
35 employees
Biotechnology, Health Care
Avalon Globocare Corp (NASDAQ: ALBT) vs
BreStem Therapeutics, Inc.
BreStem Therapeutics, Inc. United States

BreStem is a clinical stage biotech company working to fight deadly lung diseases through stem cell...

1 employees
Biotechnology, Health Care
Avalon Globocare Corp (NASDAQ: ALBT) vs
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. United States

Powerful & precise T cell therapy that attacks solid tumors while sparing normal cells.

Series B
138 employees
Biotechnology, Health Care
View all alternatives

FAQ About Avalon Globocare Corp (NASDAQ: ALBT)

Pioneering impactful biotechnology and advanced healthcare services through innovative platforms like Avalon Cell and Avalon Rehab
Avalon Globocare Corp (NASDAQ: ALBT) was founded in 2014.
Avalon Globocare Corp (NASDAQ: ALBT) operates in Biopharma, Biotechnology and Health Care. Its work centres on healthcare services, clinical-stage biotech, healthcare facility management and Avalon Cell.
Avalon Globocare Corp (NASDAQ: ALBT) has approximately 4 employees.
Avalon Globocare Corp (NASDAQ: ALBT) has completed 2 funding rounds, raising a total of $25.15M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Avalon Globocare Corp (NASDAQ: ALBT) include Smart Immune, BreStem Therapeutics, Inc., A2 Biotherapeutics, Inc., AAVantgarde, AnaptysBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Avalon Globocare Corp (NASDAQ: ALBT) and Smart Immune are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Avalon Globocare Corp (NASDAQ: ALBT), https://bouncewatch.com/company/avalon-globocare-corp-nasdaq-albt, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes